SLNO
Soleno Therapeutics Inc
Price:  
75.23 
USD
Volume:  
423,839.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SLNO Probability of Bankruptcy

The Probability of Bankruptcy of Soleno Therapeutics Inc (SLNO) is 20.56% . This number represents the probability that SLNO will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating SLNO's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

SLNO - ESG ratings

ESG ratings are directly linked to the cost of capital and SLNO's ability to raise funding, both of which can significantly affect the probability of Soleno Therapeutics Inc going bankrupt.

ESG Score 34.89
Environment Score 37.07
Social Score 40.85
Governance Score 26.77
Returns
Historical Returns (5 day) 2.16%
Historical Returns (MTD) 0.49%
Historical Returns (YTD) 67.36%
Historical Returns (13 week) 50.94%
Historical Returns (26 week) 41.86%
Historical Returns (52 week) 58.25%
Efficiency
Asset Turnover 0.07
Receiveable Turnover 5.90
Gross Margin 40.98%
Operating Margin -1,993.44%
Pretax Margin -2,606.56%
Net Margin -2,606.56%
Return on Asset (ROA) -63.91
Return on Equity (ROE) -75.31
Return on Investments (ROI) -71.50
Price Metrics
Market Cap (M) 3,754.73
Enterprise Value (M)
52 Week High 76.56
52 Week Low 36.93
Beta -2.77
Average Volume (10 day) 0.84
Average Volume (3 month) 1.01
Price / Earnings (P/E)
Price / Sales (P/S) 6,155.08
Earnings
EPS -4.26
Revenue CAGR (5 year)
Risk
Current Ratio 15.68
Quick Ratio 15.55